Kumar Kishore R, Wali G M, Kamate Mahesh, Wali Gautam, Minoche André E, Puttick Clare, Pinese Mark, Gayevskiy Velimir, Dinger Marcel E, Roscioli Tony, Sue Carolyn M, Cowley Mark J
Department of Neurogenetics, Kolling Institute of Medical Research, Royal North Shore Hospital and University of Sydney, St Leonards, 2065, Australia.
Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, Australia.
Neurogenetics. 2016 Oct;17(4):265-270. doi: 10.1007/s10048-016-0495-z. Epub 2016 Sep 28.
We performed whole genome sequencing (WGS) in nine families from India with early-onset hereditary spastic paraplegia (HSP). We obtained a genetic diagnosis in 4/9 (44 %) families within known HSP genes (DDHD2 and CYP2U1), as well as perixosomal biogenesis disorders (PEX16) and GM1 gangliosidosis (GLB1). In the remaining patients, no candidate structural variants, copy number variants or predicted splice variants affecting an extended candidate gene list were identified. Our findings demonstrate the efficacy of using WGS for diagnosing early-onset HSP, particularly in consanguineous families (4/6 diagnosed), highlighting that two of the diagnoses would not have been made using a targeted approach.
我们对来自印度的9个患有早发性遗传性痉挛性截瘫(HSP)的家庭进行了全基因组测序(WGS)。在4/9(44%)的家庭中,我们在已知的HSP基因(DDHD2和CYP2U1)以及过氧化物酶体生物发生障碍(PEX16)和GM1神经节苷脂病(GLB1)中获得了基因诊断。在其余患者中,未发现影响扩展候选基因列表的候选结构变异、拷贝数变异或预测的剪接变异。我们的研究结果证明了使用WGS诊断早发性HSP的有效性,特别是在近亲家庭中(4/6被诊断),突出表明使用靶向方法无法做出其中两项诊断。